Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • “You [advocates] push us as hard as you can. It’s your job, and you’re always mad,” said Carl Dieffenbach, Director of NIH’s Division of AIDS (DAIDS), who oversees a global HIV/AIDS research portfolio of more than US$1 billion. “And we’re always failing but in the end, there’s success. Keep pushing.”

    October 17, 2017
    Cindra Feuer
  • Please join AVAC and partners for two upcoming webinars, 10am ET on Thursday, October 26 and 9am ET on Friday, October 27. Thursday’s webinar is in partnership with the Treatment Action Group (TAG) and offers a chance to discuss the role of PrEP in HIV prevention trials. Friday’s webinar is with Dr. Carl Dieffenbach, and provides an additional opportunity to talk about the focus and priorities for the NIH-funded HIV clinical trial networks.

    October 16, 2017
  • AVAC is testing a new way to bring you information and updates! Today we are introducing a podcast, Px Pulse, where advocates, researchers, policy makers and community stakeholders can hear from each other about HIV prevention research.

    October 12, 2017
  • This blog post first appeared on Positively Aware. It represents a report taken from a session presentation summary at this year’s US Conference on AIDS (USCA), a community-based event which was held in September in Washington, DC.

    September 28, 2017
    Positively Aware
  • AVAC is pleased to announce a call for applications for participation in its inaugural PxROAR Transgender program, specifically for transgender and gender non-conforming HIV prevention advocates in Eastern and Southern Africa.

    September 28, 2017
    General
    AVAC
  • In this audio interview, Slim Abdool Karim, co-principal investigator of the landmark CAPRISA 004 study, talks about why designing trials with oral PrEP is a must—scientifically and ethically.

    September 22, 2017
    AVAC
  • Check out the latest issue of Px Wire for a deep dive into the data that suggest men who have sex with men may be protected by oral PrEP, even if they don’t dose every day—and for the reasons why these data do not apply to women. You’ll also find out why messages about global AIDS are on our mind—and what we’d change about the current global conversation.

    September 14, 2017
    AVAC
  • Are we in the Golden Age of HIV prevention, as first heralded at the 2016 International AIDS Society conference? Listen to this short interview with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH, where he explains the recent progress and upcoming HIV prevention trials, and what it will take to “put out the fire.”

    September 13, 2017
    General
    AVAC
  • We recently held a webinar with Dr. Carl Dieffenbach, the Director of the Division of AIDS (DAIDS) at the NIH’s National Institute of Allergy and Infectious Diseases, about the future of investments in the US National Institutes of Health’s (NIH) HIV clinical trial research networks in the US and internationally.

    September 6, 2017
    General
    AVAC
  • Kenyan civil society recently called a meeting with the leaders and implementers of oral pre-exposure prophylaxis (PrEP) activities in the country. The meeting’s purpose was to have a frank discussion about the role of community support in the national PrEP program, and touch on progress with HIV self-testing implementation.
    August 8, 2017
    Daisy Ouya

Pages